PC 5: Non-Invasive Respiratory Support in the Pandemic Era
Course Directors
Roberto Cosentini
Faculty
Paolo Groff, Italy
Patrick Plaisance, France
Roberta Marino, Italy
Rodolfo Ferrari, Italy
Erwan L’Her, France
Nicolas Peschansky, France
Participants
The course is designed for 25 participants (EM residents and physicians).
GOALS
Understand pathophysiology of acute respiratory failure and the effects of Non-Invasive respiratory support in COVID19 and non-COVID19 acute respiratory failure.
Understand indications and contraindications of the various methods.
Apply problem-solving to manage ventilators troubleshooting.
Understand pros and cons of Non-Invasive respiratory support in COVID19 patients.
Course format
This is highly interactive hybrid course split in 2 parts:
One is online before the pre-course (asynchronous learning)
The second one is the hands-on sessions that will be held at the Congress, and will be split in:
Six brief pre-course lectures will give you the crucial concepts on Non-Invasive Respiratory Support. They can be accessed before the on-site pre-course whenever you want (asynchronous learning)
Hands-on, during the Congress 2a (morning)
These are training sessions on 4 O2 devices/ventilators stations. All participants rotate to bring you cuting edge information on all Non-Invasive respiratory support, pros and cons, caveats, with a focus on most common cases and a specific session on COVID19 pneumonia management.
For each indication, a hands on session will be run on a different O2 devices, CPAP systems and ventilators stations with cognitive simulation of clinical scenarios.
2b. Hands-on, during the Congress (afternoon)
These are training sessions on 4 O2 devices/ventilators stations. All participants will be involved to take part in case simulation and clinical decision making on all Non-Invasive respiratory support, pros and cons, caveats, with a focus on most common cases and 2 specific sessions on COVID19.
Albania 
Austria 
Belgium 
Bosnia and Herzegovina 
Bulgaria 
Croatia 
Czech Republic 
Denmark 
Estonia 
Finland 
Georgia 
Germany 
Greece 
Hungary 
Iceland 
Ireland 
Italy 
Kosovo 
Latvia 
Lithuania 
Malta 
Moldova 
Netherlands 
Norway 
Poland 
Portugal 
Romania 
Serbia 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
Turkey 
Ukraine 
United Kingdom